Breaking news – Pagina 186 – AMD

Breaking news

Giugno 7, 2023 dario.olivero

Sotagliflozin, a dual sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes

Stougaard EB, Rossing P, Vistisen D, et al.
Diabetes Obes Metab. 2023;25(7):1874-1882.

Leggi

Giugno 7, 2023 dario.olivero

Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis

Keidai Y, Yoshiji S, Hasebe M, et al.
Diabetes Obes Metab. Pub. online 22 May 2023.

Leggi

Giugno 7, 2023 dario.olivero

Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with type 2 diabetes: a randomized clinical trial

Saxena AR, Frias JP, Brown LS, et al.
JAMA Netw Open. 2023;6(5):e2314493.

Leggi

Giugno 7, 2023 dario.olivero

Risk prediction of gestational diabetes mellitus in women with polycystic ovary syndrome based on a nomogram model

Ouyang P, Duan S, You Y, et al.
BMC Pregnancy Childbirth. 2023;23(1):408

Leggi

Giugno 7, 2023 dario.olivero

Association of prescription co-payment with adherence to glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter-2 inhibitor therapies in patients with heart failure and diabetes

Essien UR, Singh B, Swabe G, et al.
JAMA Netw Open. 2023;6(6):e2316290.

Leggi

Giugno 1, 2023 dario.olivero

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

Pennells L, Kaptoge S, Bleken H, et al.
Eur Heart J. Pub. online 29 May 2023.

Leggi

Giugno 7, 2023 dario.olivero

Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets

Benhalima K, Beunen K, Siegelaar SE, et al.
The Lancet Diabetes & Endocrinology. Pub. online 5 Jun 2023.

Leggi

Giugno 1, 2023 dario.olivero

Dapagliflozin and diuretic utilization in heartfailure with mildly reduced or preserved ejection fraction: the DELIVER trial

Chatur S, Vaduganathan M, Claggett B, et al.
Eur Heart J. Pub. online 23 May 2023.

Leggi

Giugno 1, 2023 dario.olivero

Concurrence of hyperinsulinemia and hyperuricemia significantly augmented all-cause mortality

Acevedo-Fernández M, Porchia LM, Garazi Elguezabal-Rodelo R, et al.
NMCD. Pub. online 23 May 2023.

Leggi

Giugno 1, 2023 dario.olivero

Exercise training, dietary intervention, or combined interventions and their effects on lipid profiles in adults with overweight and obesity: a systematic review and meta-analysis of randomized clinical trials

Khalafi M, Sakhaei MH, Kazeminasab F, et al.
NMCD. Pub. online 23 May 2023.

Leggi